Blood Clotting Syndrome
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
- www.ndtv.com
-
Blood Clotting May Be Root Cause Of Long COVID-19 Syndrome: Study
- Tuesday August 17, 2021
- World News | Press Trust of India
Patients with long COVID-19 syndrome continue to have higher measures of blood clotting, which may explain their persistent symptoms such as reduced physical fitness and fatigue, according to a study.
- www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
- Tuesday April 30, 2024
- India News | Indo-Asian News Service
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
- www.ndtv.com
-
Blood Clotting May Be Root Cause Of Long COVID-19 Syndrome: Study
- Tuesday August 17, 2021
- World News | Press Trust of India
Patients with long COVID-19 syndrome continue to have higher measures of blood clotting, which may explain their persistent symptoms such as reduced physical fitness and fatigue, according to a study.
- www.ndtv.com